tuesday 10 – friday 13 april - trade & investment queensland › wp-content › uploads ›...

T R A D E 2 0 1 8

HEALTH AND KNOWLEDGE

Tuesday 10 – Friday 13 April

GUIDE FOR DELEGATES

2Trade 2018

3 Trade and Investment Queensland

Welcome to the Trade 2018 Health and Knowledge Program

The Trade 2018 Trade and Investment Games Time Program brings together Queensland business and international delegates through a series of receptions, forums, networking

opportunities, site visits and more.

Health and knowledge is one of the key focus areas for the Games Time Program.

The Health and Knowledge Program will give delegates exclusive access to Queensland leaders in the fields of health, biomedical and life sciences, including aged care.

Queensland is internationally renowned for its health and knowledge expertise, with world-leading innovations in R&D, clinical trials, e-health, tropical health, vaccines and senior living.

Highlights of the Health and Knowledge Program include briefings from expert speakers, tailored business-matching sessions, and site visits to high-profile research,

health and aged care institutions.

The program will also throw a spotlight on recent health discoveries and innovations, and identify commercial opportunities in Queensland’s thriving health and knowledge sector. Delegates will have numerous opportunities to network with Queensland’s best in the field, to explore the possibilities for international collaboration, and to forge the relationships that

foster innovation in research, development and business.

Welcome to the Health and Knowledge Program. We trust it will be a rewarding experience, and that you will make

enduring business connections.

Trade 2018 is led by the Queensland Government in partnership with City of Gold Coast, and supported by the Australian Government.

The Health and Knowledge Program is presented by Trade and Investment Queensland in partnership with Queensland Health, the Queensland Department of Environment and Science, and the Queensland Department of State Development,

Manufacturing, Infrastructure and Planning.

T R A D E 2 0 1 8

Trade and Investment Queensland

Trade and Investment Queensland (TIQ) is the Queensland Government’s dedicated global business agency, helping Queensland exporters take their

products to overseas markets, and promoting Queensland as the perfect place for investment.

With eight offices across the state, and fifteen offices around the world, TIQ has one of the largest and most dynamic networks of any Queensland Government agency.

TIQ helps Queensland businesses to develop the skills, networks and acumen they need to successfully enter export markets. We also work to attract the world’s best investors and

entrepreneurs to Queensland.

TIQ’s Urban Infrastructure and Knowledge Industries (UIKI) team focuses on Queensland’s emerging and developing industry sectors, including health, knowledge and aged care. UIKI works with local

leaders in these fields to take their innovations and achievements to global markets. We also specialise in identifying local commercial opportunities for international investors, and matching Queensland’s

best with the right business partners worldwide.

If you’re thinking of bringing your investments or business to Queensland ... Our expert staff can provide market analysis and business cases to demonstrate why Queensland is the right choice for you. We can also provide introductions and support to open doors and make it

easy to do business here.

If you’d like to buy Queensland’s world-class products ... We can connect you with the best Queensland enterprises, goods and services.

TIQ – connecting Queensland business to the world

+61 7 3514 3147

[email protected]

tiq.qld.gov.au

Trade and Investment Queensland

TradeandInvestmentQld

@tradeinvestqld

Connect. Be connected.

4Trade 2018

tel:61735143147

https://www.linkedin.com/company/tradeinvestqld/

https://www.facebook.com/TradeandInvestmentQld/

6Trade 2018

Health and Knowledge Program

Events

T R A D E 2 0 1 8

Commonwealth HouseKurrawa Terrace

BROADBEACH QLD 4218

Tuesday 10 April

3.00pm–6.00pmQueensland Capabilities in Health

- Event -

This showcase is the opening event in the Trade 2018 Health and Knowledge Program.

Featuring industry presentations and a panel discussion, it will:

» profile Queensland’s health, knowledge, research and development capabilities

» highlight investment opportunities across the state, including commercial opportunities driven

by the $513 million Advance Queensland program.

This event will showcase and provide the opportunity to network with key industry professionals, researchers and senior government representatives with expertise in:

» tropical medicines, drug development

and vaccines

» medtech

» clinical trials

» R&D

» pharmaceuticals

» complementary medicine

» injury and sports management

» aged care and senior living.

Drinks and canapés will be provided.

A full listing of Queensland companies represented at this event can be found in our participant directory at the back of this booklet.

8Trade 2018

Professor Ian Frazer AC

Professor, Faculty of Medicine, The University of Queensland

Affiliate Professor, The University of Queensland Diamantina Institute

Affiliate Professorial Research Fellow, Institute for Molecular Bioscience

Professor Ian Frazer is a clinician scientist who trained as a clinical immunologist in Scotland. As a professor at the University of Queensland, he now leads a research group at Brisbane’s Translational Research Institute that

is working on the immunobiology of epithelial cancers.

Professor Frazer is recognised as co-inventor of the technology that enabled HPV vaccines, currently used worldwide to help prevent cervical cancer. He heads a biotechnology company, Admedus Vaccines, working on new vaccine technologies, and is a board member of several companies and not-for-profit organisations. He is also current president of the Australian Academy of Health and Medical Sciences, and a member of the

Commonwealth Science Council. Most recently, he was appointed chair of the Australian Government’s Medical Research Future Fund.

Professor Frazer was recognised as Australian of the Year in 2006. He received the Prime Minister’s Prize for Science and the Balzan Prize in 2008, and was elected Fellow of the Royal Society of London in 2012.

Professor Frazer was appointed Companion of the Order of Australia in the Queen’s Birthday Honours list in 2013.

- Moderator -


Kathy ConnellSenior Director, New Ventures ANZ, Johnson & Johnson Innovation Centre

Kathy is responsible for implementing the external partnerships and growth strategy for Johnson & Johnson Innovation across Australia and New Zealand.

As the technology scout for the pharmaceutical, medical device and consumer health businesses, Kathy is passionate about encouraging and building global collaborations to deliver new and disruptive healthcare solutions for people everywhere. Kathy’s remit is to identify, review and establish early-stage collaborative

research and licensing opportunities to support Johnson & Johnson’s global R&D pipelines.

She is also responsible for engaging with university, government, venture capital and industry stakeholders to help build bio-economies that can develop sustainable sources of healthcare innovations

in the long term.

- Panel -

10Trade 2018

Dr Ryan ParlettChair, Queensland State Committee, AusBioTech

Director, Business Management, Patheon Biologics – part of Thermo Fisher Scientific, Patheon Biologics Australia Pty Ltd

Ryan is responsible for managing all new and on-going business relationships for Patheon’s Brisbane cGMP manufacturing facility. Prior to joining Patheon, he spent six years in consulting roles (most recently at Deloitte),

advising biotechnology and pharmaceutical companies on R&D and financing. He also had a particular focus on advising international companies in relation to corporate structuring and accessing the R&D Tax Incentive.

Ryan was also previously involved in the identification, protection and commercialisation of both patentable and non-patentable intellectual property at UniQuest, the main commercialisation entity for the University of Queensland,

and in the Business Development Office at the QIMR Berghofer Medical Research Institute. This involved commercialisation of new drugs, vaccines, adjuvants and diagnostics across a number of disease indications.

Ryan has a PhD in oncology and immunology, undertook a post-doctoral position at the Memorial Sloan-Kettering Cancer Center in New York, and has over 17 years’ experience in the biotechnology and pharmaceutical sector.

He is currently Chair of the Queensland Branch of AusBiotech (Australia’s national industry body representing the biotechnology and pharmaceutical sector), a member of the Healthcare Committee for the American Chamber of Commerce in Australia, a member of the Advisory Committee for Griffith University’s Clinical Trial Unit, and a

longstanding member of the Licensing Executives Society, Australia and New Zealand.

Professor Pankaj SahDirector, Queensland Brain Institute at The University of Queensland

Professor Pankaj Sah is renowned for his work in understanding the neural circuitry of the amygdala, an area of the brain with a central role in learning and memory formation.

He currently leads the Queensland Brain Institute (QBI), a leading research institute focused on two of the greatest challenges of modern science: understanding brain function, and preventing and treating disorders of brain function. QBI is home to more than 450 scientists and 42 laboratory leaders. Since its inception in 2003,

the institute has published more than 1,200 papers and QBI researchers have made important advances in fundamental neuroscience and in diseases such as ageing dementia, schizophrenia and motor neurone disease.

Professor Sah’s own research uses a combination of molecular tools to examine electrophysiological signatures of different brain regions and their impact on disease. Recently, his laboratory has been working with patients

undergoing electrode implantation for deep brain stimulation, which is used to treat disorders such as Parkinson’s disease, Tourette syndrome and essential tremor.


Stephen WalkerGeneral Manager, Sanofi Consumer Healthcare Australia and New Zealand

Stephen is a successful global marketing executive with a career spanning more than 30 years. He has extensive business leadership and commercial experience, including sales and general management across

developed and emerging economies.

Prior to joining Sanofi, Stephen had 20 years’ experience at GlaxoSmithKline in a variety of senior marketing roles across Australia, New Zealand, North America and Asia. He possesses a unique blend of consumer, over-

the-counter, innovation and digital expertise, gained on a regional and global level.

Stephen is a passionate proponent of the healthcare industry and is committed to consumers, patients and customers, ensuring they have access to quality over-the-counter vitamins, supplements and mineral products.

Michael WalshDirector-General, Queensland Health

Michael is Director-General of Queensland Health, which provides a public health and hospital system for almost 5 million people and employs approximately 90,000 people.

He is also chair of the Australian Health Ministers Advisory Council (AHMAC), which provides advice to the COAG Health Council, and is on the Board of the Australian Digital Health Agency, which is responsible for My Health Record. Michael is also on the Board of Brisbane Diamantina Health Partners, an NHMRC-accredited

Advanced Health Research and Translation Centre.

Over the past 17 years, Michael has held executive positions in both the New South Wales and Queensland health systems. He was Chief Executive of HealthShare NSW and inaugural Chief Executive of eHealth NSW. In Queensland, he has worked in both social and economic portfolios at the Deputy Director-General level,

including health, education and infrastructure.

Michael has also worked in the private sector, including as a principal with PwC. He holds a Master of Business Administration, Bachelor of Arts (Hons) in psychology, Bachelor of Science in human movement, and Bachelor of Education. Michael has a passion for organisational excellence and leading values-based teams achieving

outcomes that improve the lives of all Australians.

12Trade 2018

Robert WebbSupply Chain Solutions Manager, Asia Pacific, Cook Medical

Rob leads Cook’s Supply Chain Solutions effort, driving innovation in the healthcare supply chain. This includes working with healthcare systems, distribution channel partners, and other relevant stakeholders to streamline

and enhance the supply-chain process to deliver healthcare efficiencies.

Rob has more than 30 years’ experience in the medical industry, including roles in pharmaceuticals and in-vitro diagnostics. While Business Development Manager for SmithKline Beecham, he successfully reduced the path to market for new products by 40%. One of the many highlights of his 12-year career with Cook was

establishing Cook Medical Korea as General Manager.

Rob received his MBA from Southern Cross University, and is a Fellow of the Australian Institute of Management.


Institute for GlycomicsGriff i th University, Gold Coast Campus

58 Parklands DriveSOUTHPORT QLD 4215

Wednesday 11 April

10.00am–12.30pm Opportunities in eHealth

- Event -

Queensland is embracing innovation to position itself as a world-leader in digital health.

Through this event, you’ll learn how Queensland is harnessing the power of data and

technology to achieve improved quality of care, patient safety and productivity.

You’ll also hear about:

» e-health capabilities in hospitals, research and business

» Queensland’s eHealth Investment Strategy

» Queensland’s expertise in disruptive healthcare technologies

» opportunities for commercialisation and export

» international opportunities for partnership and collaboration.

Co-hosted by Queensland Health and TIQ, the event will feature industry presentations and opportunities to network with some of Queensland’s most innovative health companies.

A light lunch will be provided during the networking component.

14Trade 2018

Michael WalshDirector-General, Queensland Health

Michael is Director-General of Queensland Health, which provides a public health and hospital system for almost 5 million people and employs approximately 90,000 people.

He is also chair of the Australian Health Ministers Advisory Council (AHMAC), which provides advice to the COAG Health Council, and is on the Board of the Australian Digital Health Agency, which is responsible for My Health Record. Michael is also on the Board of Brisbane Diamantina Health Partners, an NHMRC-accredited

Advanced Health Research and Translation Centre.

Over the past 17 years, Michael has held executive positions in both the New South Wales and Queensland health systems. He was Chief Executive of HealthShare NSW and inaugural Chief Executive of eHealth NSW. In Queensland, he has worked in both social and economic portfolios at the Deputy Director-General level,

including health, education and infrastructure.

Michael has also worked in the private sector, including as a principal with PwC.

He holds a Master of Business Administration, Bachelor of Arts (Hons) in psychology, Bachelor of Science in human movement, and Bachelor of Education.

Michael has a passion for organisational excellence and leading value-based teams achieving outcomes that improve the lives of all Australians.

- Moderator -


Dr Richard Ashby AM Chief Executive, eHealth Queensland

Dr Ashby is Chief Executive of eHealth Queensland, which is responsible for advancing healthcare through digital innovation.

In 2016, Dr Ashby oversaw the successful delivery of Australia’s first large-scale digital hospital, the Princess Alexandra Hospital, as the Chief Executive of Metro South Hospital and Health Service. He believes that digital

healthcare is one of the most important revolutions in healthcare – providing connected, interactive care models that support personalised, precise and well-informed treatment of patients across care settings and care teams.

Dr Ashby is regarded as one of the state’s most experienced clinicians and health administrators. In 2010, he was awarded a Member of the General Division of the Order of Australia for service to emergency medicine, medical administration, and a range of professional associations. He is active across a broad range of areas,

including teaching, research and consultancy.

Dr Ashby’s other roles include:

» board member, Australian e-Health Research Centre

» board member, Australian Prostate Cancer Research Centre

» board member, Queensland University of Technology Council

» Chair, eHealth Executive Committee

» Chair, Queensland Policy and Advisory Committee on Health Technology

» Senior Responsible Owner, Queensland Digital Hospital Program.

Luke Baxby Partner, Health Economics & Human Services, Deloitte Australia

Luke has more than 15 years’ experience in the health industry, with a focus on:

» system policy

» service planning

» funding models (capitation and output)

» policy design

» commercial analysis

» infrastructure and capital planning

» costing and affordability analysis

» casemix and financial management.

- Speakers -

16Trade 2018

Dr Sankalp KhannaResearch Scientist, Australian e-Health Research Centre

Dr Khanna is a Research Scientist in the Health Data Analytics team at the Australian e-Health Research Centre, which is a joint venture between CSIRO and the Queensland Government. The centre’s research

program – focusing on digital innovation in health data, clinical applications, and new services – is transforming the way health care is delivered.

Dr Khanna’s current research focuses on applying the techniques of artificial intelligence and machine learning to model, analyse, predict, simulate and optimise patient flow through Australian public hospitals. His research interests include applied artificial intelligence, prediction and forecasting, planning and scheduling, distributed

constraint reasoning, and decision-making and learning under uncertainty.

Dr Khanna is also a senior Adjunct Research Fellow at Griffith University’s Institute for Integrated and Intelligent Systems, a member of the steering committee for the Pacific Rim International Conference on Artificial

Intelligence, and an active member of the Health Informatics Society of Australia.

Associate Professor Brent RichardsMedical Director of Innovation and Director of Critical Care Research, Gold Coast

Hospital and Health Service

Associate Professor, Griffith University and Bond University

An intensive care specialist, Brent has a passion for clinical research. He has worked as a director of intensive care and an executive director of surgery, been a project executive for a clinical information system rollout, and

held roles on numerous state and national committees.

Brent has combined these skills to co-found IntelliHQ, a not-for-profit organisation dedicated to improving patient and system outcomes through the use of artificial intelligence.


Institute for GlycomicsGriff i th University, Gold Coast Campus

58 Parklands DriveSOUTHPORT QLD 4215

Wednesday 11 April

12.30pm–1.30pmGold Coast Health and Knowledge Precinct Showcase

- Event -

The Gold Coast Health and Knowledge Precinct is a 200ha (500-acre) precinct encompassing Griffith University, Gold Coast University Hospital, a new private hospital,

and a range of prominent corporations.

Supported by $5 billion in infrastructure, the area will provide over 26,000 jobs by completion, providing a vibrant community where people live, learn and work.

The precinct offers unique opportunities for local and international investors. This showcase will allow delegates to learn more about these exciting opportunities.

18Trade 2018

Di DixonProject Director, Gold Coast Health and Knowledge Precinct

Di has worked in major infrastructure project management, economic development, stakeholder management, strategy development and investment attraction in both the UK and Australia over the past 20 years.

Di is currently leading the Gold Coast Health and Knowledge Precinct (GCHKP) delivery team, focused on identifying business, research and investment attraction opportunities for GCHKP on behalf of City of Gold

Coast, Griffith University, Gold Coast Health and the Queensland Government.

Di is responsible for delivering the GCHKP Investment Attraction Strategy, which involves facilitating land-development opportunities after the Commonwealth Games, attracting targeted global investment, and

attracting business and research enteprises.

Dr Chris DavisGeneral Manager, Institute for Glycomics, Griffith University

Chris obtained an honours degree and PhD in synthetic medicinal chemistry from Griffith University on the Gold Coast. Following graduation, for two years he worked in a biotechnology start-up company developing

anti-bacterial drug candidates that he had co-invented during his PhD.

Following the trade sale of that company, Chris worked for commercialisation company Uniquest Pty Ltd seeking venture capital investment to enable the development of new drug and vaccine discoveries and the

licensing of drug and vaccine technologies to biotechnology and pharmaceutical companies.

In 2009, Chris returned to Griffith University as General Manager at the Institute for Glycomics, where he is responsible for domestic and international business strategy; technology commercialisation; fundraising across

the philanthropic, government, industry and private sectors; and general institute operations.

- Speakers -


gchkp.com.au

GOLD COAST HEALTH AND KNOWLEDGE PRECINCT

Invest in the future – in a precinct driving global innovation through jobs and knowledge collaboration.

Asia-Pacific’s emerging health and innovation hub, the 200-hectare Gold Coast Health & Knowledge Precinct (GCHKP), is a unique global business location for high-tech industry development, research collaboration and jobs of the future, transforming Australia’s leading lifestyle city.Supported by $5 billion in infrastructure, including the world-class Griffith University, the $1.76 billion Gold Coast University Hospital and a new private hospital, the Precinct offers a combination of expertise, infrastructure, land and lifestyle unique in Australia.

This exciting precinct will generate 12,400 new high-value jobs to ultimately support over 26,000 full-time equivalent positions and generate $2.9 billion in gross economic benefit for the Gold Coast (source Ernst & Young).The GCHKP includes the 2018 Commonwealth Games™ (GC2018) Athletes Village on a 29-hectare site, including 7 hectares of parkland. This $550 million legacy project provides the foundation for a vibrant community to flourish in the future. Following GC2018, over 9 hectares of land will be available for targeted commercial development as the next stage of growth.

“Griffith is excited to be part of the rapidly growing world-class health and knowledge precinct. The precinct is allowing our students and staff to train, interact and research in a modern, cutting-edge setting, offering huge opportunity through business and industry linkage and subsequent collaborative investment to accelerate the growth of the city’s economy through the creation of jobs and attraction of talent.”

Professor Ned Pankhurst, Senior Deputy

Vice Chancellor and Senior Vice President, Griffith University

Why invest in the GCHKP?

At the contemporary convergence of health, science and engineering and empowered by digital technology, GCHKP researchers, clinicians and companies collaborate at the cutting-edge of innovation.

This modern, multi-disciplinary approach positions the Precinct to deliver nextgeneration medicine and advanced manufacturing, and comprehensive innovation in preventative health care.

Exciting opportunities exist for health, knowledge and commercial activities to locate within the Precinct for small, medium and larger corporations – from incubator and co-working through to anchor tenant and greenfield development opportunities.

Be part of a vibrant, self-contained but connected economic hub driving collaboration and entrepreneurship.

Leverage long-term commercial and collaborative partnerships with internationally recognised research and specialised services already in the Precinct.

Have immediate access to supporting infrastructure, including advanced telecommunications, upgraded roadways and public transport, including the light rail system – linking to the rest of the city and to heavy rail.

The GCHKP represents a smart investment in Australia’s fastest growing major city, with a stable, diversifying economy, competitive taxes, skilled workforce and a climate and lifestyle second to none.

As a globally competitive precinct driving knowledge, innovation and commercialisation, the GCHKP will:

strengthen and diversify the Gold Coast economy

create jobs by attracting businesses from a range of industry sectors to locate to the city

support the establishment and growth of new health, IT and knowledge-based businesses

attract significant investment to the Gold Coast

stimulate knowledge, information and technology sharing between co-located universities, research organisations and businesses

foster an entrepreneurial culture to drive innovation and create new opportunities for health and knowledge-related business and services

attract talent such as internationally recognised researchers, clinicians and collaborators

expand facilities for clinical training of new doctors, nurses, researchers, health professionals and educators on the Gold Coast.

Strengths and opportunities:

flexible range of greenfield development sites on the doorstep of the hospitals and university with diverse commercial and clustering opportunities

streamlined State Government Priority Development Area (PDA) approval process of 40 days

anchor tenancies and range of building tenancies including temporary start-up/incubator space

pathways into Precinct include research and commercial partnerships, clinical trials and industry links to new advanced design and manufacturing facility

great public transport links – light rail connected with two G: Link stations in the precinct and upgrades to the arterial road network

walking distance to sporting facilities, major parks and future retail and services

financial and non-financial investment attraction incentive program offering planning, development and financial support, including land, infrastructure and rate discounts

a key growing employment area for the Gold Coast with a skilled labour pool

integrated with the existing infrastructure, a new master-planned mixed-use residential community with quality lifestyle benefits offers students, workers and the community a vibrant place for people to live, work and learn.

Collaborate

All levels of government, education, health and research organisations, industry and the private sector are working together to deliver the vision for the GCHKP.

The GCHKP Project Office has been established, and is actively working on behalf of the City of Gold Coast, Griffith University, Gold Coast Health and Queensland Government to ensure the delivery of a world-class hub of knowledge, innovation, employment and investment.

For more information contact the GCHKP Project Office:

P +61 7 5552 7039M +61 404 892 076E [email protected].

Victoria Towers34 Scarborough Street

SOUTHPORT QLD 4215

Wednesday 11 April

2.30pm–4.00pmVictoria Towers – Gold Coast – Aged Care

Victoria Towers is the first project in Australia to combine aged care and seniors living in a high-rise development.

Victoria Towers is a 35-storey building on Australia’s scenic Gold Coast.

The building includes an aged-care facility on the first 4.5 levels.

Remaining levels are for seniors (over 50s) living independently in 1-, 2- and 3-bedroom apartments with stunning views of the Gold Coast Broadwater, ocean and hinterland. The complex contains 220 of these

independent living apartments, which have been purchased by residents under a strata title property system.

Victoria Towers’ aged-care facility is government accredited and meets stringent compliance requirements. Residents requiring care as assessed by the government can access care in the facility and be partly funded by

the Australian Government.

GenBridge Pty Ltd played a key role in the creation of the Victoria Towers community. GenBridge brings together leading health, retirement and aged-care management professionals to ensure the effective delivery

of projects and services. On the Victoria Towers project, GenBridge obtained government funding and building certification to operate the aged-care facility. The company then achieved accreditation of the facility for the maximum term of three years and operated it successfully it under the name of Nobel Life Pty Ltd until it was

sold to Estia Health.

Seniors are now seeking well-located high-rise apartments with nearby care options should they need them in the longer term. Victoria Towers demonstrates a new model for aged care and seniors living into the future.

22Trade 2018

Princess Alexandra Hospital199 Ipswich Road

WOOLLOONGABBA QLD 4102

Wednesday 11 April

4.00pm–5.30pmPrincess Alexandra Hospital Site Visit – eHealth

Come on a fascinating tour of Australia’s first large-scale digital hospital. Learn about some of Queensland’s e-health innovations in action, in one of the

country’s leading academic and research health centres.

PAH is one of Australia’s leading tertiary referral teaching hospitals. It provides care in most major adult specialties, including acute medical, surgical, mental health, cancer, rehabilitation and allied health services.

It’s also home to a number of statewide services, including the Queensland Spinal Cord Injuries Service and the Queensland Liver Transplant Service. PAH has 873 beds and employs 5,522 staff.

Established in 1956, the PAH has a long history of clinical excellence and innovation. It is internationally recognised for its expertise in transplantation and trauma management and is Queensland’s major centre for

liver, kidney, bone, cartilage and cornea transplants. The hospital plays a leading role in medical research and is a key partner of Queensland’s Translational Research Institute, which is based on the PAH campus.

In November 2015, PAH became Australia’s first large-scale digital hospital, with the successful roll-out of a fully electronic medical record across the organisation, along with integrated digital systems and devices. PAH

is now the exemplar site for Australia in the successful implementation of digital hospital technology.

PAH was the first hospital in Australia to receive the prestigious Magnet® designation and was recently re-designated for a third time. Magnet® is an international program recognising ongoing commitment to the

highest quality clinical care and leadership.

Other digital innovations will also be discussed on the site visit.


1 Wil l iam StreetBRISBANE QLD 4000

Thursday 12 April (Stream 1 – Health)

9.15am–12.30pmClinical Trials Program

- Event -

Queensland is a leader in high-quality clinical trials designed to expedite the commercialisation process while providing rigorous scientific data.

Queensland is a destination of choice for clinical trials with our experienced service providers, generating data that is acceptable in North America, Europe and Asia.

Today you will learn about Queensland’s expertise and strength in this area. QIMR Berghofer Medical Research Institute and the Translational Research Institute are fine examples of our medical research and clinical trials facilities, as are Luina Bio and Patheon, the only two organisations in Australia with dedicated current Good

Manufacturing Practice (cGMP) grade contract manufacture of biopharmaceutical active ingredients.

This session will familiarise you with Queensland’s clinical trials capabilities, advantages and opportunities.

24Trade 2018

1.00pm–5.00pmBusiness Matching Program


Participants will include:

» Queensland Health

» Queensland Department of State Development, Manufacturing, Infrastructure and Planning

» Queensland Clinical Trials Network

» ERA Consulting

» Deloitte

» major research institutes

» private-sector providers.

Topics for discussion will include:

» policy overview

» Queensland’s clinical trial landscape

» Queensland’s Biomedical 10-year Roadmap and Action Plan

» regulatory framework.

An industry roundtable will feature representatives from:

» Translational Research Institute

» QIMR Berghofer Medical Research Institute

» Queensland University of Technology

» Griffith University

» University of Queensland

» Sunshine Coast University Clinical Research Centre

» Luina Bio

» Patheon

» QPharm.

A light lunch will be provided.

Delegates may have the opportunity to participate in tailored business matching, meeting with Queensland companies in the areas of aged care, biotech, med tech and

clinical trials if requested.



Thursday 12 April (Stream 2 – Aged Care and Senior Living)

9.00am–5.00pmAged Care Program

- Event -

Queensland is a leader in aged care and senior living, with a full-service offering from design and building of aged-care facilities to management, nursing, digital solutions

and more. Queensland companies are increasingly working with partners in the Asia-Pacific to provide senior-living solutions to ageing populations in the region.

This session will introduce you to some of the leading players in Queensland’s aged-care sector, and their world-leading services and products.

26Trade 2018

Presenters will include:

» Queensland Health

» Thomson Adsett architects

» CSIRO – Australian eHealth Research Centre

» aged-care training providers

» active-ageing technology providers

» aged-care nutrition providers.

Topics for discussion will include:

» introduction to Queensland’s Aged Care and Senior Living Consortium

» government policy and active ageing programs

» innovative design to improve elderly living and care

» home monitoring of chronic disease

» training, technology and nutrition.

Roundtables will include representatives from:

» ConnectUs Life

» Phenix Health

» Jeta Gardens

» M3dicine

» Flavour Creations

» Sanofi

» Provital Pty Ltd.

A light lunch and afternoon tea will be provided as part of the program.


Various Brisbane locations, commencing at 1 Will iam Street

BRISBANE QLD 4000

Friday 13 April (Stream 1 – Health)

9.00am–6.30pm Queensland Research Institutes Site Visits

- Event -

This day-long session organised in partnership with the Department of Environment and Science will provide delegates with exclusive access to some of Queensland’s

leading research and industry organisations.

Visits are scheduled to:

» The University of Queensland:

› Australian Institute for Bioengineering and Nanotechnology

› Institute for Molecular Bioscience

› Queensland Brain Institute

» Queensland University of Technology:

› Institute of Health and Biomedical Innovation

» QIMR Berghofer Institute for Medical Research

» Translational Research Institute (TRI)

A networking lunch will be hosted by TRI.

At the conclusion of the day, all delegates are invited to join us for an hour-long tour of the Brisbane River by chartered City Cat, enjoying light refreshments to round out the week and conclude the

Trade 2018 Health and Knowledge Program.

28Trade 2018

Various Brisbane locations, commencing at 1 Will iam Street

BRISBANE QLD 4000

Friday 13 April (Stream 2 – Aged Care and Senior Living)

9.00am–6.30pm Aged Care Site Visits

This day-long session will provide delegates with exclusive access to some of Queensland’s leading aged-care facilities and research institutions.

Visits are scheduled to:

» Jeta Gardens – residential aged-care facility offering high care, low care, ageing in place, dementia-specific

and respite care

» Tunstall Healthcare – provider of connected care and connected health solutions, supported by assistive

technology and 24/7 monitoring

» Queensland Brain Institute at The University of Queensland – research institute focusing on brain function and

the prevention and treatment of disorders of brain function, such as dementia and Alzheimer’s.

At the conclusion of the day, all delegates are invited to join us for an hour-long tour of the Brisbane River by chartered City Cat, enjoying light refreshments to round out the week and conclude the

Trade 2018 Health and Knowledge Program.


Jamie MerrickDirector-General, Department of Environment and Science

Mario PennisiCEO, Life Sciences Queensland Ltd

Professor Ian WronskiDeputy Vice Chancellor, Tropical Health and Medicine, James Cook University

Professor Louis SchofieldDirector, Australian Institute of Tropical Health and Medicine

Professor Frank GannonDirector and CEO, QIMR Berghofer Medical Research Institute

Professor Lyn Griff ithsExecutive Director, Institute of Health and Biomedical Innovation,

Queensland University of Technology

Professor Matt BrownDirector of Genomics, Institute of Health and Biomedical Innovation and School of

Biomedical Sciences, Queensland University of Technology

Professor Ian Frazer ACAmbassador and Chair of Foundation Board, Translational Research Institute

- Speakers on this day will include -

30Trade 2018

Professor Carolyn MountfordCEO and Director of Research, Translational Research Institute

Professor Josephine ForbesGroup Leader Mater Research, Translational Research Institute

Louise MorlandDirector Communications and Marketing, Translational Research Institute

Dr Nagaraj GopisettyBusiness Development and Innovation, Education Manager,

Translational Research Institute

Dr Kym BakerGeneral Manager, Patheon Biologics

Dr Clair Sull ivanMedical Lead Digital Health, Co-Chair DHIN, Consultant Endocrinologist and HITEC

Co-Director, Clinical Excellence Division, Queensland Health

Professor Robyn Ward AMDeputy Vice-Chancellor (Research) and Vice President (Research),

The University of Queensland

Professor Mark MorrisonChair and Group Leader Metagenomics,

The University of Queensland Diamantina Institute


32Trade 2018

Health and Knowledge Program

Directory

T R A D E 2 0 1 8

3Dme

3Dme is a globally recognised and multi award winning Creative Studio that prides itself on a unique in-house production process that revolutionises the way we think about health and medical teaching and learning products. Above all, we make

complex information easy to understand – with health and education comes opportunity and choice.

3Dme specialises in knowledge transfer to a specific audience. We create captivating 3D visuals and game-like e-learning software, complemented by engaging digital storytelling to improve educational outcomes.

Luke BrannellyM a n a g i n g D i r e c t o r

+61 7 5529 7266 [email protected] 3dme.com.au

Admedus Immunotherapies

Admedus Immunotherapies is a clinical stage company founded in 2000 by Professor Ian Frazer. Admedus develops and commercialises patented technology for improving immune responses to nucleic acid vaccines assigned by UniQuest Pty Ltd

and developed at The University of Queensland.

Admedus is majority owned by ASX-listed Admedus Ltd, and has laboratories at the Translational Research Institute at the Princess Alexandra Hospital. Our overall objective is to use unique optimisation technology to produce immunotherapies for infectious diseases and cancers. Clinical development currently focuses on therapeutic vaccines for the herpes and human

papilloma viruses.

Our research has shown that using combined technologies can provide protection in a number of infectious diseases and tumour-challenge animal models. Admedus has five granted US patents protecting its codon optimisation nucleic acid

technology, which enhances protein expression in the targeted cell or tissue and results in an improved humoral response. The second component of the technology, also US patented, is to use nucleic acid encoding ubiquitin to enhance degradation

of the same protein, which results in an increased cell mediated response.

Neil FinlaysonC h i e f E x e c u t i v e O f f i c e r

+61 7 3443 6996 [email protected] admedusimmunotherapies.com

c r e a t i v e s t u d i o

34Trade 2018

Trad

e 20

18

| c

ompa

ny d

irec

tory

Advance QueenslandDepartment of Innovation, Tourism Industry Development and the Commonwealth Games

Queensland Government

Advance Queensland is the Queensland Government’s vision for the future and its investment in a stronger Queensland economy. Funding of $513 million is supporting programs that drive innovation, build on the state’s natural advantages, and

help raise Queensland’s profile as an attractive investment destination.

Through Advance Queensland, we are:

» supporting jobs by encouraging innovation and collaboration in industry

» turning ideas into action by investing in research and technologies, attracting new investment, building global partnerships, and encouraging businesses to start and grow in Queensland

» making lives better by delivering world-leading health and environmental protection outcomes and building connected communities

» working together to tackle today’s challenges and grasp tomorrow’s opportunities by diversifying the economy and giving our

children the skills and education they need to succeed.

13 QGOV (13 74 68) [email protected] advance.qld.gov.au

Austrade

The Australian Trade and Investment Commission (Austrade) is responsible for the promotion, attraction and facilitation of productive foreign direct investment into Australia.

Austrade helps international companies establish and build their business in Australia.

We understand the challenges of investing. We seek to provide the information required to make good investment decisions and to provide a coordinated approach that saves investors time and money.

[email protected] austrade.gov.au


Trade 2018 | company directory

36Trade 2018

proudly sponsored by the

Queensland Government’sAdvance Queensland initiative

31 October – 2 November 2018 Brisbane Convention and Exhibition Centre, Southbank www.ausbiotechnc.org #AusBiotech

Australian e-Health Research Centre (CSIRO)

A joint venture between CSIRO and the Queensland Government, the Australian e-Health Research Centre (AEHRC) is CSIRO’s national digital health research program. AEHRC’s program includes research into health informatics, biomedical informatics

and health services.

Research into health informatics is developing and applying data-collection and analytics tools that support improved decision-making. These include tools to support interoperability of health data and predictive analytics tools for health-service and

patient-decision support. Research into biomedical informatics is developing advanced processing algorithms for analysing biomedical data, such as whole genome sequences and multidimensional biomedical imaging data sets to inform clinical care

and clinical research.

Research into health services is exploring the use of mobile and tele-health technology to change the way services are delivered to improve patient outcomes. This includes a world-first randomised controlled trial in mobile health for cardiac

rehabilitation, and national tele-health trials in ageing and remote tele-health services. Our health Internet of Things research uses in-home sensors to support the aged to live at home safely.

AEHRC’s research is transforming the way healthcare is delivered.

Dr David HansenC h i e f E x e c u t i v e O f f i c e r

+61 7 3253 3627 [email protected] aehrc.com

Australian Institute for Bioengineering and Nanotechnology

The Australian Institute for Bioengineering and Nanotechnology (AIBN) seeks to deliver innovative solutions to society’s problems through sustainable materials, healthy living and translational success.

Our research is underpinned by AIBN’s Five Pillars of Research:

» stem cell ageing and regenerative engineering

» precision nanomedicine

» advanced materials

» agriculture nanotechnology

» industrial biotechnology.

These pillars focus AIBN’s research efforts on developing new products, processes and devices for improving human health, the environment and quality of life. In this way, the institute goes beyond basic research to promote and develop the growth of

innovative industries, which will benefit Queensland and Australian economies.

Professor Alan RowanD i r e c t o r a n d S e n i o r G r o u p L e a d e r

+61 7 3346 3877 [email protected] aibn.uq.edu.au



Australian Institute of Tropical Health and Medicine at James Cook University

The Australian Institute of Tropical Health and Medicine (AITHM) at James Cook University (JCU) is the nation’s only medical research institute dedicated to improving the health and wellbeing of people in the tropics. The institute’s research outputs focus on the most pressing health issues facing both tropical Australia and the Indo-Pacific, and are recognised worldwide.

AITHM undertakes research that leads advancements in understanding, diagnosing and preventing infectious diseases, strengthening health systems and building capacity towards improving health outcomes for the region.

Since its establishment in 2013, AITHM has grown to be a research leader and significant collaborating partner worldwide. Its internationally recognised research programs are bolstered by expertise in epidemiology, health systems, social science, mathematical modelling, pathogeneses, immunology and vaccine development. These areas are supported by experts in the

fields of health economics, statistics and bioinformatics.

Professor Louis SchofieldD i s t i n g u i s h e d P r o f e s s o r a n d D i r e c t o r

+61 7 4781 3122 [email protected]

Professor Ian WronskiD e p u t y V i c e C h a n c e l l o r , T r o p i c a l H e a l t h a n d M e d i c i n e

+61 7 4781 5330 [email protected] jcu.edu.au

Cardihab

Cardihab™ is a digital health company that supports optimum health for patients at risk of, or living with, heart disease.

Cardihab’s scientifically validated Digital Cardiac Rehabilitation solution uses smartphone apps and a web portal to give clinicians the ability to deliver more convenient, flexible and engaging cardiac rehabilitation services to patients.

A randomised controlled trial conducted in Queensland demonstrated that an in-home cardiac rehabilitation program leads to greater compliance and better health outcomes. The trial demonstrated an increase in cardiac rehabilitation uptake, adherence

and completion rates, resulting in better outcomes for patients, clinicians and health service administrators.

Gus TaddeoC h i e f E x e c u t i v e O f f i c e r

+61 412 710 614 [email protected] cardihab.com

38Trade 2018

Trad

e 20

18

| c

ompa

ny d

irec

tory

Centre for Online Health – The University of Queensland

The University of Queensland’s Centre for Online Health (COH) is world-renowned for its telehealth expertise.

COH staff are research translation experts and pride themselves on a broad range of research projects that deliver solutions to real-world clinical problems. COH’s tripartite mission of telehealth research, teaching and education, and clinical service

provision makes it unique amongst peer university centres.

COH is one of the foundation centres of the Faculty of Medicine’s Centre for Health Services Research.

Professor Anthony SmithD i r e c t o r

+61 7 3176 1685 [email protected] coh.centre.uq.edu.au

ConnectUs Life

ConnnectUs Life provides care and wellbeing software services for the aged care industry.

RightMinder from ConnectUs Life is a world-first, patent-pending, affordable fall-detection and first-alert system for smartphones and smartwatches. RightMinder has been engineered to address the needs of an ageing population, overcoming the social and emotional obstacles that exist around wearable safety devices in aged care. RightMinder provides peace of mind without being ‘front of mind’ to

more than 40,000 registered carers and wearers, globally.

Learn more at rightminder.com

Ben SlaterJ o i n t M a n a g i n g D i r e c t o r a n d C h i e f I n f o r m a t i o n O f f i c e r


Drew SteptoeJ o i n t M a n a g i n g D i r e c t o r a n d C h i e f E x e c u t i v e O f f i c e r

+61 423 009 082 [email protected] rightminder.com ®



Cook Medical Australia

Founded in Indiana in 1963, Cook Medical pioneered many of the medical devices now commonly used to perform minimally invasive medical procedures. Since its inception, Cook has operated as a family-held private corporation, dedicated to a patient-first business philosophy. Today, the Cook Group has grown to 60 companies internationally, including Cook Medical Australia.

Cook Medical Australia has been operating in Australia since 1979, and was one of the first businesses to operate from Brisbane Technology Park. Its state-of-the-art manufacturing and R&D facility now employs more than 600 people. Cook Medical Australia

manufactures endovascular stent grafts for the treatment of aortic aneurysms, and is one of the few sites in the world that custom-makes these products to fit individual patient anatomies. The company also develops and manufactures products used in the IVF process.

Cook Medical’s Australian operations also double as the headquarters for the Asia-Pacific region.

Robert WebbM a n a g e r – A s i a P a c i f i c S u p p l y C h a i n S o l u t i o n s


Ann DamienN e w T e c h n o l o g y A s s o c i a t e

+61 7 3434 6326 [email protected] cookmedical.com

Deloitte Australia

At Deloitte, we believe that we’re only as good as the good we do. All the facts and figures that talk to our size and diversity and years of history, as notable and important as they may be, are secondary to the truest measure of Deloitte:

the impact we make in the world.

When people ask, “what’s different about Deloitte?” the answer resides in the many specific examples of where we have helped Deloitte member firm clients, our people, and sections of society, in Australia and around the world, to achieve remarkable goals, solve complex

problems or make meaningful progress. Deeper still, it’s in the beliefs, behaviours and fundamental sense of purpose that underpin all that we do. With over 150 years of hard work and a commitment to making a real difference, our organisation has grown in scale and diversity.

We are now approximately 7,000 people in Australia, across 14 offices, and 245,000 people in 150 countries and territories around the world, providing audit, tax, legal, financial advisory, risk advisory, and consulting services—yet our shared culture remains the same. For us, good isn’t good enough. We aim to be the best at all that we do—to help clients realise their ambitions; to make a positive difference

in society; and to maximise the success of our people. What really defines us is our drive to make an impact that matters in the world.

Larissa HursthouseM a n a g e r , G l o b a l I n v e s t m e n t a n d I n n o v a t i o n I n c e n t i v e s ( G i ³ )


Luke BaxbyP a r t n e r , H e a l t h E c o n o m i c s & H u m a n S e r v i c e s

+61 7 3308 7202 [email protected] deloitte.com.au

40Trade 2018

Trad

e 20

18

| c

ompa

ny d

irec

tory

Dementia Training AustraliaDementia Training Australia (DTA) is funded by the Australian Government to provide dementia education and

training across Australia.

We combine the expertise of five universities and Dementia Australia to deliver a coordinated national approach to dementia training for individuals and organisations.

Consortium members are:

» University of Wollongong (consortium lead and central coordination)

» Dementia Australia

» La Trobe University

» Queensland University of Technology

» University of Western Australia

» Wicking Dementia Research and Education Centre (University of Tasmania).

dementiatrainingaustralia.com.au

Department of Environment and ScienceQueensland Government

The Department of Environment and Science recognises the enormous value a healthy environment, innovative society and economy, and vibrant culture make to our lives.

As a diverse organisation, the department brings together key areas of work to achieve our objectives for a better Queensland. This includes leading the development of a science strategy for government, providing scientific expertise to protect and manage our

environment and natural resource base, and delivering targeted activities that help develop Queensland’s science sector.

A key approach in supporting the development of the Queensland science sector is to attract and retain the best and brightest research minds, and build the state’s capability and reputation to conduct and translate innovative research that leads to sustainable economic, social and environmental benefits. Queensland’s life sciences has benefited from a long history of Queensland Government investment to establish the state as a highly attractive knowledge hub with successes in health,

agriculture, environment and industrial biotechnology. Current strategic partners include Johnson & Johnson, Emory University (Atlanta USA), and Siemens Innovation.

+61 7 3170 5864 [email protected] qld.gov.au/science



Department of State Development, Manufacturing, Infrastructure and Planning


The Department of State Development, Manufacturing, Infrastructure and Planning is driving Queensland’s economic prosperity by championing the interests of business and industry.

Developing the biomedical sector is one of our priorities. Our target for 2027 is for Queensland to be recognised as a national and international leader in biomedical technologies, products, systems and services that are innovative, sustainable, and embedded in local and global supply chains. The Queensland Biomedical 10-Year Roadmap and Action Plan provides the foundations and

strategic direction for realising the economic development potential of the state’s biomedical capabilities.

Through the $513 million Advance Queensland suite of programs, the Queensland Government is investing in priority sectors, including the biomedical industry. Advance Queensland is:

» providing unprecedented support to start-ups and entrepreneurs

» fostering world-class research talent and a highly skilled and educated workforce

» supporting cutting-edge applied research projects founded on strong industry collaborations

» building capability, skills and knowledge by attracting international companies and developing local companies

» helping to progress biomedical products, processes or services to a stage where they can attract self-sustaining investment.

13 QGOV (13 74 68) [email protected] statedevelopment.qld.gov.au

DoseMe

DoseMe is the first company in the world to offer precision-dosing software developed for clinical use at the point of care. The DoseMeRx platform significantly improves dosing accuracy and patient outcomes by providing real-time, dose-related

decision support using readily available patient data.

DoseMe Crunch is built on the same algorithms that underpin DoseMeRx. It analyses retrospective and previously under-utilised patient data to empower health services to optimise medication use, benchmark clinical dosing practices and monitor

medication management performance.

DoseMe Asia Pacif ic +61 7 3151 3033 [email protected]

DoseMe USA +1 (832) 358-3308 [email protected] doseme.com.au

42Trade 2018

Trad

e 20

18

| c

ompa

ny d

irec

tory

eHealth QueenslandQueensland Government

eHealth Queensland provides statewide leadership on the strategic direction, delivery and management of digital healthcare solutions and services for Queensland’s 16 public hospitals and health services and the Department of Health.

Key functions include:

» developing and providing advice on statewide eHealth innovation, strategy, planning, standards, architecture and governance

» delivering clinical, corporate and infrastructure ICT-enabled health programs in line with the eHealth vision and investment priorities

» providing modern ICT infrastructure and customer support for desktop, mobile, smart devices, telehealth, data centres, network and security.

Statewide digital healthcare capabilities will be designed to relieve pressures on public hospital infrastructure and provide connected models of care that support personalised and well-informed treatment of patients. Ultimately, this will result in

improved safety, quality of care and faster treatment for patients.

+61 7 3170 4770 [email protected] health.qld.gov.au

ERA Consulting (Australia)

ERA Consulting (Australia) is a member of ERA Consulting Group, a leading independent regulatory affairs and product-

development consultancy with four office locations worldwide.

ERA specialises in complex biotechnology-related medicines, and has worked on more than 500 products, including rDNA

proteins and peptides, vaccines, gene and cell therapies, tissue-engineered products, and innovative chemical entities.

ERA can assist with every aspect of product development, from preclinical and CMC to support with clinical trial design and

applications, agency interactions, through to complete eCTD-based submissions to regulators in Australia, US and EU.

Daina VanagsS e n i o r C o n s u l t a n t

+61 7 3331 3900 [email protected] eraconsulting.com



Extensia

Extensia is a leading Australian health software company proudly developed and owned in Queensland.

Extensia software enables patients and providers to make sense of a range of health data with a single click. All relevant information from all sources can be viewed where required and in the format required. This access to information can give

patients greater autonomy over their healthcare.

Extensia is used across Australia, including on an integrated care program on the Gold Coast, for aged-care plans in Western Australia’s south-west region, and to help manage research data at Sydney’s George Institute for Global Health.

Extensia makes health information available where you want it, when you want it and how you want it.

Emma HossackC h i e f E x e c u t i v e O f f i c e r

+61 7 3292 0255 [email protected] extensia.com.au

Flavour Creations

Flavour Creations is an award-winning, Brisbane-based specialist food and drink manufacturer. We research and develop innovative dysphagia and nutrition products to support a healthy lifestyle and improve the lives of people with dysphagia.

Flavour Creations is focused on improving the lives of our customers by providing food and drink solutions that not only taste great but offer maximum nutritional density and choice. Flavour Creations supplies to hospitals, residential aged-care facilities

and directly to consumers living in the community – both in Australia and internationally.

Cathie WattsH e a d o f C o m m u n i t y a n d Q u e e n s l a n d S a l e s M a n a g e r

+61 7 3373 3000 [email protected] flavourcreations.com.au

44Trade 2018

Trad

e 20

18

| c

ompa

ny d

irec

tory

GenBridge

GenBridge brings together leading health, retirement and aged-care management professionals to ensure the effective delivery of health, retirement and aged-care services.

GenBridge is a multidisciplinary organisation founded by professionals who have managed hospitals and significant aged care and retirement portfolios, placed values on these portfolios, and advised extensively in this sector. This experience extends to

technology facilitation and internal audit.

Recently, GenBridge has worked on the innovative 35-storey Victoria Towers project located on the Gold Coast, one of Australia’s best-known beachside destinations. Victoria Towers includes an aged care facility funded by the Australian

Government on its first 4.5 levels, while other levels comprise 220 independent-living apartments for over 50s.

GenBridge obtained government funding and building certification to operate the aged-care facility, which was the first facility of its type in Australia to operate in a high-rise environment in combination with independent-living apartments.

+61 7 3391 3866 [email protected] genbridge.com.au

Gold Coast Health and Knowledge Precinct

Asia-Pacific’s emerging health and innovation hub, the 200ha Gold Coast Health and Knowledge Precinct (GCHKP) is a unique global business location for high-tech industry development, research collaboration, and jobs of the future.

The precinct employs almost 10,000 people and caters for up to 20,000 students. It is home to the world-class Griffith University, co-located with the $1.76 billion Gold Coast University Hospital, the new Gold Coast Private Hospital and the

GC2018 Athletes Village, to be transformed into a vibrant $550 million mixed-use community for living, learning and working.

The precinct offers a combination of expertise, infrastructure, land and lifestyle unique in Australia, offers easy transport access and is serviced by the Gold Coast light rail.

A total of 9ha of prime greenfield land are available for health and innovation investment. Investment incentives are available, and a project office has been established to facilitate global opportunities.

Di Dixon P r o j e c t D i r e c t o r

+61 7 5552 7039 [email protected] gchkp.com.au



Great Health Guide

Great Health Guide™ is a progressive media company that is determined to bring positive change to the health and wellbeing of women around the world.

Publishing content solely from doctors and other health specialists, Great Health Guide™ offers credible and factual information from global health experts. Great Health Guide™ provides a suite of media options for the discerning woman, including a

bi-monthly eMagazine called Great Health Guide™ and a set of six books entitled The Health Specialists’ Series, which has recently received interest from international literary agents.

The Great Health Guide Audio Library is the latest innovation, with audios being aired on radio stations around Australia. It is anticipated that the audio library will be released to an international audience in 2018.

Kathryn DoddF o u n d i n g D i r e c t o r

+61 403 235 676 [email protected] GreatHealthGuide.com.au

Griffith Health – Clinical Trial Unit

Adjacent to the Gold Coast University Hospital and part of the Gold Coast Health and Knowledge Precinct, Griffith University’s Clinical Trial Unit provides state-of-the-art facilities and professional coordination services for phase I–IV clinical trials.

As a core research facility of Griffith University, we support staff and collaborators to conduct a wide range of investigator-initiated trials across a diverse range of therapeutic areas. We also provide trial services to commercial clients such as the

biotech, pharmaceutical, nutraceutical and complementary medicine industry, as well as clinical research organisations.

We offer a range of GCP-aligned facilities, including:

» experienced investigators and research nurses with GCP certification

» trial start-up, study coordination and project management

» 4-bed procedure room with emergency trolley, AED, ECQ and IV infusion equipment

» phlebotomy room with separate lab processing area, including refrigerated and non-refrigerated centrifuges

» dedicated monitoring space

» drug preparation room with temperature-controlled storage facilities and biosafety cabinet

» commercial-grade data-logged fridges and -20 °C and -80°C freezers

» secure document storage

» patient lounge and kitchenette

» 6 consultation rooms

» GCP-compliant trial facilities.

Associate Professor Evelin TiralongoD i r e c t o r , C l i n i c a l T r i a l U n i t ( G r i f f i t h H e a l t h )

+61 7 5678 0366 [email protected] www2.griffith.edu.au/health/clinical-trial-unit

46Trade 2018

Trad

e 20

18

| c

ompa

ny d

irec

tory

Griffith Institute for Drug Discovery (GRIDD)

GRIDD’s unique resources, dedicated researchers and network of international partners underpin our search for revolutionary drug discoveries to treat:

» cancer

» infectious diseases

» neurological diseases

» antibiotic resistance

» spinal cord injury

» acquired brain injury.

We have an established high-throughput screening capability, and an existing pipeline of lead compounds against various diseases.

GRIDD’s research is supported by NatureBank, a unique drug-discovery platform based on natural product extracts derived from Australian plants, fungi and marine invertebrates. The 60,000 optimised natural product fractions are ready for high-throughput screening against any disease. GRIDD is also home to Compounds Australia, Australia’s only integrated facility

in compound and natural product management and logistics with overall storage capacity of 600,000 samples. Compounds Australia provides compound management services to its member organisations and enables access to its open collections to

health and medical researchers worldwide.

Professor Jennifer MartinD i r e c t o r

+61 7 3735 6000 [email protected] www2.griffith.edu.au/institute-drug-discovery

Griffith University and Griffith Enterprise

Griffith University is ranked amongst the top 3% of universities globally, and has over 50,000 students spread across 5 campuses.

Griffith’s health and bioscience research institutes collaborate with industry and public health sectors to deliver global benefits through outcomes such as novel drug leads, vaccines for combating infectious diseases, and healthy living programs.

Griffith’s key life science research institutes are:

» Griffith Institute for Drug Discovery (GRIDD)

» Menzies Health Institute Queensland (MHIQ)

» Institute for Glycomics.

Griffith Enterprise is the university’s commercialisation office. Griffith Enterprise helps organisations identify and engage with the university’s specialist expertise and research capabilities, and to access its people, inventions and knowledge-based products and services. Griffith Enterprise staff have significant commercial experience and understand the needs of business partners.

We offer flexible and tailored engagement terms and a professional approach to doing business with Griffith University.

Ujjwal DuaB u s i n e s s & I n n o v a t i o n M a n a g e r

+61 7 5678 7536 [email protected] griffith.edu.au/griffith-enterprise



Health Informatics Society of Australia

The Health Informatics Society of Australia (HISA) is Australia’s peak professional body for the digital health community.

HISA members are health informaticians, clinicians, researchers, healthcare managers and executives, data analysts, designers, project managers, business analysts, technologists and innovators.

Special digital health interest areas include cybersecurity, clinical informatics, nursing informatics, health UX, digital hospitals and precision medicine. A dynamic calendar of events includes educational speakers, networking and a major scientific conference.

With corporate collaboration, university sector support, strong government relationships and industry connections, our members have unlimited opportunities for digital health career advancement and professional development.

As a leading member of the global health informatics and digital health network, HISA is also the forum for sharing international best practice, digital healthcare trends and health system innovation. In its 25th year, the Health Informatics Society of Australia

continues to fulfil its vision of transforming healthcare through information and technology

Greg MoranB u s i n e s s D e v e l o p m e n t M a n a g e r

+61 3 9326 3311 [email protected] hisa.org.au

Institute for Glycomics (Griffith University)

The Institute for Glycomics is a flagship biomedical research institute at Griffith University’s Gold Coast campus, and is an integral component of the Gold Coast Health and Knowledge Precinct.

The institute houses some of Australia’s most renowned research leaders and state-of-the-art facilities. This rich research environment provides exceptional postgraduate education programs for our region’s future scientists.

Our unique, multidisciplinary approach and extraordinary research capacity is being used to develop the next generation of drugs, vaccines and diagnostics to fight diseases with global impact.

From the laboratory bench to the patient’s bedside, translational outcomes are the ultimate goal of our research.

The Institute for Glycomics has a comprehensive portfolio of research programs focusing on some of the most significant viral pathogens (influenza, parainfluenza, dengue virus, HIV and emerging alphaviruses); bacterial infections (N. meningitidis, N.

gonorrhoeae and Group A Streptococcus); parasitic diseases (including the malaria vaccine, PlasProtecT® currently in human clinical trials); and cancers.

+61 7 5552 8051 [email protected] www2.griffith.edu.au/institute-glycomics

48Trade 2018

Trad

e 20

18

| c

ompa

ny d

irec

tory

Institute of Health and Biomedical Innovation(Queensland University of Technology)

QUT’s Institute of Health and Biomedical Innovation (IHBI) uses the latest technology and brings together the best minds from around the world to develop solutions for health problems affecting the global community.

IHBI has more than 1,300 members representing a broad spectrum of disciplines, including medical practitioners, biomedical scientists, nurses, psychologists, public health experts, optometrists, exercise physiologists and biomedical engineers. Our research focuses on prevention, intervention and translation, and has a particular emphasis on chronic disease and ageing,

health determinants and health systems, and injury prevention and trauma management. Areas of strength align with ailments that affect millions, such as cancer, cardiovascular disease, diabetes, infectious diseases, obesity, arthritis, asthma, mental

health, dementia, Alzheimer’s disease, eye disorders and chronic wounds. IHBI research aims to develop new and innovative solutions to challenging global health issues, bridging the gap between clinical science and better health, and ensuring better

health becomes a reality in our lifetime.

Professor Lyn Griff ithsE x e c u t i v e D i r e c t o r


Professor Mia Woodruff +61 7 3138 7778 [email protected] qut.edu.au/ihbi

IntelliHQ

Believing that artificial intelligence (AI) is healthcare’s next major disrupter, Dr Brent Richards has joined with Dr Kelvin Ross to co-found IntelliHQ, a not-for-profit company dedicated to improving health outcomes through AI.

IntelliHQ’s vision is to improve both patient and system outcomes through careful use of available and developing AI-based technologies, including predictive and prescriptive algorithms, image recognition, voice technologies, and medical Internet of

Things. Key to this is bringing together researchers, educators, small and large companies, and investors, to form an ecosystem to support this vision, with clear intentions of rapid product development and commercialisation. A key strategy for our Gold Coast-

based organisation is to develop early-stage products with Gold Coast Health, providing early customer validation. We believe data is the new ‘oil’. Accordingly, IntelliHQ is building a Precision Medicine Data platform from which new products can be developed,

streaming physiology data to better understand and individually manage patients using their data phenotype and AI.

Dr Brent Richards +61 7 3151 3033 [email protected]

Dr Kelvin Ross +61 414 768 952 [email protected] IntelliHQ.com.au



James Cook University

James Cook University (JCU) is one of the world’s leading institutions focusing on the tropics. With main campuses in the tropical cities of Townsville, Cairns and Singapore, JCU’s teaching and research are shaped by the university’s presence in Asia and its proximity to the wet tropics, dry savannahs and iconic great Barrier Reef. JCU’s focus is on the health, environment and

populations of tropical regions.

JCU has a particular emphasis on the health status, workforce and medical needs of tropical communities. Its teaching programs have a strong medical science base with an emphasis on practical clinical skills. With world-class facilities, JCU

provides nationally and internationally recognised, innovative and advanced postgraduate programs and research initiatives. JCU has established three World Health Organisation Collaborating Centres, and hosts the Australian Institute of Tropical

Health and Medicine. It also has strong links with regional health services via its membership of the Tropical Australian Academic Health Centre.

Ranked amongst the top 4% of universities worldwide, JCU’s vision embodies a brighter future for people in the tropics, through graduates and discoveries that make a difference.

Professor Ian WronskiD e p u t y V i c e C h a n c e l l o r , D i v i s i o n o f T r o p i c a l H e a l t h a n d M e d i c i n e

+61 7 4781 5330 [email protected] jcu.edu.au

Jeta Gardens Aged Care

Jeta Gardens is an approved aged-care provider, operating 178 residential places and home care services in Bethania, Queensland. Jeta also operates a retirement village comprising 33 villas and 32 apartments, with extensive community

facilities. Jeta applies its internationally recognised 4H model of care and senior lifestyle amenity to all operations, and its Bethania facility has won numerous international awards.

Internationally, Jeta’s operations include an 80-place residential facility in Johor State Malaysia and two joint-venture projects in China’s Shaanxi and Zhejiang provinces. Jeta is also consulting on three other Malaysian projects and is involved in a joint

venture to develop revolutionary aged care and retirement living facilities in Selangor State, Malaysia.

In Queensland, future plans include a geriatric rehabilitation hospital adjacent to our existing Bethania operations, 400 ‘intergenerational’ apartments, and an international college providing tertiary and vocational training for nursing and health

sciences students. Numerous investment opportunities are available in our Australian operations and in our Asian projects, such as those currently underway in Malaysia.

Choe Lam TanM a n a g i n g D i r e c t o r


Peter C HennessyD i r e c t o r / C o m p a n y S e c r e t a r y

+61 412 730 582 [email protected] jetagardens.com

50Trade 2018

Trad

e 20

18

| c

ompa

ny d

irec

tory

THE COMMONWEALTHINNOVATION FORUM 2018

Event Host

brought to you by Destination Gold Coast

TCIFbrought to you by

5 - 6 April 2018

Brisbane Convention and Exhibition Centre

Join us for The Commonwealth Innovation Forum 2018.

With speakers from across The Commonwealth Nations, the Forum will explore the

innovation that will feed, fuel and heal the peoples of The Commonwealth.

www. tc i f . co

Travel Partner

GENE 2018

INNOVATION WEEK

F R I D AY 2 6 O C TO B E RT R X 1 8 & G E N E

S U N D AY 2 8 - T U E S D AY 3 0 O C TO B E RR E G I O N A L S AT E L L I T E E V E N T S

AU S B I OT E C H D AY 1

L S Q CO C K TA I L F U N C T I O N

W E D N E S D AY 3 1 N O V E M B E R

T H U R S D AY 1 N O V E M B E RL S Q B R E A K FA S T

AU S B I OT E C H D AY 2

F R I D AY 2 N O V E M B E RAU S B I OT E C H D AY 3

INNOVATION WEEK 2018 IS A SERIES OF COORDINATED EVENTS HELD

ACROSS QUEENSLAND TO SHOWCASE AND HIGHLIGHT THE ROLE OF

INNOVATION DERIVED FROM LIFE SCIENCES R&D, AND THE CONTRIBUTION

THAT IT MAKES TO THE ECONOMIC AND SOCIAL WELLBEING OF OUR STATE.

I N N O VAT I O N W E E K 2 0 1 8 . CO M . AU

2 6 O C T O B E R - 2 N O V E M B E R 2 0 1 8

GENE 2018

T R A V E L PA R T N E R

Johnson & Johnson Innovation Centre

Johnson & Johnson Innovation seeks to positively affect human health through innovation.

We do this by providing scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of

Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our local partnering offices, regional innovation centres, JLABS, Johnson & Johnson Innovation – JJDC Inc, and our business development teams. Together, we create customised deals and novel collaborations that speed development of innovations to

solve unmet patient needs.

Our mission is to create the leading global innovation network to generate transformational healthcare solutions through value-creating partnerships.

Tamlyn O’ConnorR e l a t i o n s h i p s a n d O p e r a t i o n s M a n a g e r

+61 7 3138 6258 [email protected] jnjinnovation.com

LifeCare Furniture

LifeCare Furniture is Australia’s premier aged-care and contract furniture manufacturing expert, with manufacturing plants in both Australia and Asia.

Founded in the early 1990s, LifeCare Furniture has become the leading Australian supplier of tailored bedroom, lounge, dining, occasional and outdoor furniture to the Australian health and aged-care industries, as well as completing projects in Japan,

Hong Kong and Taiwan. We pride ourselves on supplying quality, purpose-built furniture that creates an aesthetically pleasing, home-like environment for residents.

We are proud to have grown and developed our contract furniture arm into a full-scale service area. We work with all areas of the health, property development and interior design industries – from aged-care developments through to resorts, hotels,

office and administration projects ... and much more.

Ian Reinhardt D i r e c t o r

+61 7 3216 2282 lifecarefurniture.com.au

52Trade 2018

Trad

e 20

18

| c

ompa

ny d

irec

tory

Life Sciences Queensland Ltd

Life Sciences Queensland (LSQ) Ltd is an Australian peak industry group, working to assist the growth of individual firms and organisations, and build the profile, capacity and capability of the life sciences sector to ensure long-term economic, social and

environmental benefits to Queensland.

LSQ highlights the key role that life sciences innovation plays in feeding, fuelling and healing our citizens.

Our major goals are to facilitate the future growth and sustainability of Australia’s life sciences industry, and to enhance Queensland’s national and international reputation as a centre for commercial and research excellence and

innovation in life sciences.

LSQ represents more than 190 member organisations.

Mario PennisiC h i e f E x e c u t i v e O f f i c e r

+61 7 3331 3999 [email protected] lsq.com.au

Longevum

Longevum is a start-up company that aims to extend quality lives by leveraging medical sensors and mobile devices to improve the connection between various parties interested in improving an individual’s health. These parties include patients and health

professionals, customers and insurance companies, employees and employers, and the elderly and aged-care providers.

Longevum is the creator of Gevity, an innovative health management platform focused on behaviour change.

Gevity is a cloud-based platform that helps users create healthy habits by facilitating health monitoring, health planning and health risk assessment activities, involving relevant third parties as required.

Loch BloomfieldF o u n d e r a n d C h i e f E x e c u t i v e O f f i c e r

+61 417 605 084 [email protected] longevum.com



Luina Bio

Luina Bio is a Brisbane-based drug development and contract manufacturing organisation (CMO) serving the pharmaceutical, biotechnology and veterinary industries.

Drawing on more than 20 years of contract manufacturing experience, Luina Bio scientists have the expertise, training and experience to ensure a successful outcome to any contract manufacturing project. Utilising our TGA/APVMA-licensed facilities

operating to international cGMP standards, we can provide manufacturing solutions for both biological and small-molecule drugs. We offer a comprehensive set of services, including GMP production of recombinant proteins, vaccines, live biotherapeutics, and synthetic molecules for human and veterinary use. Lumina Bio can generate GMP material for pre-clinical studies, Phase 1, 2 & 3 clinical trials and the marketplace. We also offer a range of support services, including GMP document preparation, regulatory

advice, CMC or dossier package development, product distribution, and stability studies.

Les Til lackC h i e f E x e c u t i v e O f f i c e r


Dr Timothy EvansP r o j e c t M a n a g e r

+61 7 3273 9176 [email protected] luinabio.com.au

Made4u

Made4U weighted blankets are specially made blankets that mould to your body and create a gentle pressure all over the body like a warm hug. This gentle pressure helps relax the nervous system and encourages the release of a much-needed hormone

called serotonin. Serotonin is the hormone responsible for the feeling of happiness, which also aids in the release of the melatonin hormone that helps and promotes sleep.

Weighted blankets have been a tool used by occupational therapists for some time now, as many therapists and parents have found that they have benefits for children with autism and sensory disorders.

Some of the noted benefits include promoting and improving sleep; improving focus; reducing anxiety; calming ‘meltdowns’; and making transitions easier. Current research also suggests that weighted blankets have demonstrated therapeutic effects for

people experiencing post-traumatic stress disorder, anxiety, insomnia, menopause, restless legs and dementia.

+61 412 405 157 [email protected] www.facebook.com/Made4UCreations

54Trade 2018

Trad

e 20

18

| c

ompa

ny d

irec

tory

Magnetica

Magnetica is an Australian biomedical engineering company specialising in next-generation magnetic resonance imaging (MRI) technologies. We develop and deliver high-performance products for use in MRI systems, including superconducting magnets,

gradient coils and radio frequency coils.

Magnetica specialises in:

» innovative high-field MRI superconducting magnet design, utilising our asymmetric magnet IP for clinical and pre-clinical applications

» design and manufacture of high-performance RF and gradient coils for clinical and pre-clinical applications.

Magnetica holds a suite of international patents protecting its unique magnet, gradient and RF coil designs. Our products result in smaller, lighter, faster and more easily deployed MRI systems. Clinicians benefit from superior diagnostic performance in conventional clinical, remote, disaster, sports and military settings. Patients benefit from access to advanced imaging closer

to the point of care, and an enhanced clinical experience.

Magnetica is currently certified under ISO 9001:2008, and is transitioning to ISO 13485:2016 certification.

Duncan StovellC h i e f E x e c u t i v e O f f i c e r

+61 403 731 970 [email protected] magnetica.com

M3DICINE

Founded in 2013, M3DICINE Pty Ltd researches and develops new and emerging medical-device technologies. Our core expertise lies in artificial intelligence and machine learning, embedded systems and hardware engineering,

and software engineering.

M3DICINE understands that the future of healthcare lies in smart personal devices and diagnostics. We design powerful, simple-to-use devices that empower everyone to manage and understand healthcare better.

M3DICINE’s first product is Stethee, an AI stethoscope that will disrupt medical technology around the world. Stethee combines powerful machine-learning techniques with simple hardware design to deliver detailed health-related data to users. Stethee has applications in the home, medical profession and veterinary care, and sales and distribution deals have already

been negotiated in a number of countries.

Andrew MortonP a r t n e r a n d U s e r S u p p o r t

+61 434 526 269 [email protected] stethee.com



Microba

Microba is a microbial genomics company providing the public with access to cutting-edge technology to analyse their personal gut microbiome. Using one of the most advanced sequencing technologies, Microba empowers consumers to gain a

deeper understanding of their personal microbiome, including bacteria, archaea, fungi, and protists at species level.

Individuals receive a detailed overview of the microorganisms inhabiting their gut and what they might be doing, which can provide insight into overall gut health. Personalised dietary suggestions to promote the growth of beneficial bacteria

are also included.

Microba Insight™ is the only test in Australia that provides consumers with the whole picture. While other services use 16S rRNA testing, which sequences only a small part of a single bacterial gene, Microba uses metagenomics, which sequences all

the genes from the microorganisms in a sample.

Microba will launch in June 2018.

Blake Wil lsC h i e f E x e c u t i v e O f f i c e r

+61 408 455 190 [email protected] microba.com

Niagara

Niagara is an Australian manufacturer and retailer of therapy products that has traded for almost 70 years.

Niagara has helped millions of people worldwide with medical devices designed and clinically proven to increase blood flow, aid joint mobilisation, reduce musculo-skeletal pain and excess swelling, and assist in the treatment of wounds and pressure ulcers.

Niagara products use cycloid vibration therapy to improve circulation. This aids in the treatment of conditions such as varicose veins, swollen ankles, diabetes complications, night cramps, fluid retention and bed sores. It also supports lymphatic drainage.

Niagara has invested in extensive medical research and our products are Class 2a medical devices listed on the Australian Register of Therapeutic Goods.

Niagara supplies its products through a variety of sales channels, including home care (end-user), hospitals, nursing/aged care homes, the aged care community, retail stores, physiotherapists, occupational therapists, insurance companies and major employers.

Simon FarnsworthN a t i o n a l E x p o r t M a n a g e r

+61 7 3386 7222 [email protected] niagara.com.au

56Trade 2018

Trad

e 20

18

| c

ompa

ny d

irec

tory

Office of the Queensland Chief ScientistQueensland Government

The Office of the Queensland Chief Scientist leads science policy in Queensland and plays a critical role in promoting science to the general community.

The Office:

» leads the development of, and provides input to, science policy, to help meet economic challenges and build the state’s science capability

» oversees strategic reviews of science capability and investment, which inform government investment in research and development

» provides targeted reviews, advice on leadership and change management

» acts as Queensland’s science ambassador, fostering collaboration among government, research, industry and community sectors.

Dr Christine Williams is currently the acting Queensland Chief Scientist. Dr Williams leads the development and implementation of science policy to optimise opportunities for science in Queensland.

Dr Christine Wil l iamsA / C h i e f S c i e n t i s t

+61 7 3215 3739 [email protected] chiefscientist.qld.gov.au

Patheon Biologics

Patheon Biologics, a part of Thermo Fisher Scientific, provides end-to-end pharmaceutical services to support the entire biotechnology and pharmaceutical life cycle.

Thermo Fisher’s pharma services solutions help customers accelerate innovation and drive productivity in drug development and commercialisation – from small and emerging to large biotechnology and pharmaceutical companies for both large and

small molecules.

At Patheon’s mammalian-based cGMP facility in Brisbane, Australia, we support our clients to undertake large-scale GMP manufacturing of biopharmaceuticals.

Dr Ryan ParlettD i r e c t o r B u s i n e s s M a n a g e m e n t , P h a r m a S e r v i c e s

+61 427 218 840 [email protected] thermofisher.com/patheon



Phenix Health

Phenix Health is an Australian company that seeks and sources opportunities to make the world we live in a better place. We offer collaborative solutions and workflows in medical administration that enable our clients to better service their patients,

residents and populations.

Phenix Health has been at the heart of many and diverse health-related projects. Our directors have been involved in a range of projects, from development of hospitals and 24/7 operations to population health research and health business strategy.

Their combined experience spans almost half a century.

Our vision is to help clients implement innovative practices and technologies for scalable efficiency.

We are ready to take our expertise around the world to improve the advancement and long-term viability of the world’s healthcare systems.

Phenix Health has offices in Australia, Singapore and India, and is currently developing relationships in China.

Gill ian Alexis C h i e f E x e c u t i v e O f f i c e r

+61 7 3914 9119 [email protected] phenixhealth.com

Provital

Queensland-based Provital is a 100% Australian-owned company established in 2010. They are a leader in the Tocotrienols (T3) and Yunzhi PSP natural health supplement market.

T3 Ultrabsorb Formula is a 100% natural supplement with reported benefits including anti-aging, UV protection, cardiovascular health, brain health and liver health.

It has been demonstrated to have an antioxidant effect 60 times stronger than common Vitamin E. It is manufactured in Australia in a TGA-approved GMP facility.

Yunzhi PSP is a 100% natural premium quality Turkey Tail mushroom extract formulated to effectively maintain a strong and proper immune system. Clinical results using this substance have been published in a leading international research journal.

Eddie YuenP r o d u c t M a n a g e r

+61 7 3865 3771 [email protected] provital.com.au

58Trade 2018

Trad

e 20

18

| c

ompa

ny d

irec

tory

QIMR Berghofer Medical Research Institute

QIMR Berghofer Medical Research Institute is a world-leading translational research institute where research develops from the laboratory bench to the patient’s bedside.

With almost 900 scientists, students and support staff, and more than 50 state-of-the-art laboratories, QIMR Berghofer is one of Australia’s largest and most successful institutes. For over 70 years, QIMR Berghofer has led advances in the understanding,

prevention, control, diagnosis and treatment of disease. Today, in collaboration with research institutions, governments and industry throughout the world, QIMR Berghofer focuses on cancer, infectious diseases, chronic disorders and mental health,

and has developed impressive capability in genomics across these programs.

Professor Frank GannonD i r e c t o r a n d C h i e f E x e c u t i v e O f f i c e r


Goslik SchepersB u s i n e s s D e v e l o p m e n t M a n a g e r

+61 7 3845 3734 [email protected] qimrberghofer.edu.au

Q-Pharm

Q-Pharm is a state-of-the-art early-phase clinical trials company, providing a broad range of high-quality services to commercial and academic clients around the world. Since 2002, Q-Pharm has safely and successfully conducted more

than 400 early-phase clinical trials in over 15,000 volunteers. Q-Pharm’s highly qualified teams and leaders have a wealth of experience in clinical development, enabling Q-Pharm to understand the needs of a diverse range of clients, and to meet and

exceed their expectations.

Clinical trials conducted at Q-Pharm are accepted by regulators throughout the world, including those in Australia, Europe, Asia, and North and South America. Our speciality clinical trial services include:

» comparative PK and SAD/MAD/food effect studies

» complex first-in-human studies

» vaccine studies

» disease-challenge models

» clinical development strategy

» study design consultation.

Thor BergM a r k e t i n g M a n a g e r

+61 7 3845 3636 [email protected] qpharm.com.au



Queensland Brain Institute – The University of Queensland

Established in 2003, the Queensland Brain Institute (QBI) is a leading research institute focused on two of the greatest challenges of modern science: understanding brain function, and preventing and treating disorders of brain function.

Since its formation, the institute has been remarkably productive, publishing more than 1,200 papers. The quality of work produced by QBI researchers is demonstrated by the Institute’s National Health and Medical Research Council (NHMRC) and Australia Research Council (ARC) grant success, with more than $110 million in competitive grant funding attracted to date.

QBI is currently led by Professor Pankaj Sah, who is renowned for his work in understanding the neural circuitry of the amygdala, an area of the brain with a central role in learning and memory formation.

QBI is home to more than 450 scientists and 42 laboratory leaders.

Professor Pankaj SahD i r e c t o r

+61 7 3346 6311 [email protected] qbi.uq.edu.au

Queensland Brain Institute – Clem Jones Centre for Ageing Dementia Research

The Clem Jones Centre for Ageing Dementia Research (CJCADR), housed within the Queensland Brain Institute at The University of Queensland, is Australia’s first and largest research centre dedicated to the prevention and treatment of dementia.

Professor Jürgen Götz, a world leader in cutting-edge research on Alzheimer’s disease, is CJCADR’s inaugural Director. CJCADR is driven by the insight that fundamental research is required to solve the ageing crisis, with diseases such as

Alzheimer’s posing an increasing challenge to our society. CJCADR currently has 10 laboratories of researchers.

Professor Elizabeth Coulson P r o f e s s o r , S c h o o l o f B i o m e d i c a l S c i e n c e s

+61 7 3365 9022 [email protected] qbi.uq.edu.au/CJCADR

60Trade 2018

Trad

e 20

18

| c

ompa

ny d

irec

tory

Queensland Health Queensland Government

Queensland Health comprises the Department of Health and 16 individual hospital and health services (HHSs).

The department is responsible for the overall management of Queensland’s public health system, and has a service agreement with each HHS to deliver public health services in their local area.

The department’s role includes:

» providing strategic leadership and direction for health through the development of policies, legislation and regulations

» developing statewide plans for health services, workforce and major capital investment

» managing major capital works for public sector health service facilities

» purchasing health services

» supporting and monitoring the quality of health service delivery

» delivering specialised health services, providing ambulance, health information and communication technology and statewide health support services.

Queensland Health is pursuing innovation by investing in smart technology, research, practices and international collaboration that can turn new ideas into better healthcare.

+61 7 3234 0111 health.qld.gov.au

Queensland Health – Aged CareQueensland Government

Queensland has a high standard of aged and community care, highly skilled health professionals, and integrated facilities.

An ageing population is driving demand for aged care and senior-living services. Many older people are choosing to stay living at home, connected to family and community. This requires new types of support services and assistive technologies for

independent living.

The sector benefits from an environment that supports innovation, researchers, start-ups and companies. Queensland’s capabilities include infrastructure, design and planning, aged care and community care services and products. Queensland has a strong medical device and information technology sector, with researchers and companies bringing assistive technologies to support seniors living and aged care. The sector includes private aged care operators, not-for-profit community organisations,

education providers and researchers developing and supplying assistive technologies.

Queensland has a number of export-ready providers across the aged care sector.

+61 7 3234 0111 health.qld.gov.au



Queensland Health – Health Innovation, Investment and Research Office


The Health Innovation, Investment and Research Office (HIIRO) aims to improve the health and wellbeing of Queenslanders through a coordinated and collaborative approach to health innovation, investment and research.

HIIRO provides a strategic framework for research, investment and innovation activities to ensure Queensland Health is positioned to meet the state’s current and future healthcare needs, create and maintain jobs, boost the state’s economy and

improve patient outcomes.

HIIRO focuses on three priority areas to strengthen Queensland’s approach to health and medical research and innovation:

» trade and investment

» research

» clinical trials, research ethics and governance.

+61 7 3708 5071 [email protected] health.qld.gov.au/hiiro

QUT – Dementia Collaborative Research Centre

Located at the Institute of Health and Biomedical innovation, we’re researching how ageing affects people, their families and carers, with a specialised focus on dementia.

Our research in dementia and ageing investigates:

» ageing and links to wound healing, pain and self-management

» links between nutrition, exercise, the immune system and healthy ageing

» improving posture, balance and gait in older people to avoid falls

» understanding the links between ageing, visual impairment and neurological disease

» the effects of ageing on vision and driving performance

» effective communication between healthcare workers and people living with cognitive impairment and carers

» integrated health service models to improve outcomes from aged and healthcare services

» environmental legibility, accessibility and safety for older people with cognitive issues

» preparedness of dementia carers for natural disasters

» non-pharmacological intervention development for people with dementia.


62Trade 2018

Trad

e 20

18

| c

ompa

ny d

irec

tory

Skin Analytics

Every 2 minutes someone is diagnosed with melanoma, and every 10 minutes someone dies from the disease.

Melanoma is one of the world’s fastest-growing cancers, with its incidence doubling every 10–20 years.

It is also the second-most common cancer for young adults. Importantly, 97% of melanoma is survivable if it is found early enough, but many patients delay seeking treatment, leading to a higher mortality rate.

By combining dermoscopy and artificial intelligence, Skin Analytics can bring dermatologist-level screening into any GP’s office, or even into a patient’s home.

That means we can help to find melanoma earlier and achieve our goal of helping more people survive the disease.

Tim DalyM a n a g i n g D i r e c t o r

+61 409 117 917 [email protected] skin-analytics.com

Suncayr

Suncayr is a team of engineers and scientists who are united in helping people who have been touched by cancer.

With skin cancer one of the fastest growing and most preventable (greater than 95%) forms of cancer, we want to change the way the world sees ultraviolet exposure.

Suncayr has invented SPOT – a UV-indicating sticker that changes colour when sunscreen is no longer providing protection to skin. Suncayr aims to give parents the knowledge they need to ensure their children are ‘sun safe’ every day.

Suncayr is a Canadian start-up, with operations in Australia and the USA.

Derek JouppiC o - f o u n d e r a n d C h i e f O p e r a t i n g O f f i c e r

+61 413 296 550 [email protected] suncayr.ca



Sunshine Coast Health Institute

The Sunshine Coast Health Institute (SCHI) is a dedicated education, training and research facility, contributing to the Sunshine Coast University Hospital’s (SCUH) vision of ‘providing excellent care through collaboration, enquiry and education’.

Teaching and research is integral to the SCUH. SCHI plays a vital role in training the next generation of staff, fostering innovation, and maintaining a culture of ongoing clinical audit, redesign and practice improvement to support excellence in the

delivery of care.

Emily Thompson B u s i n e s s A d v i s o r

S u n s h i n e C o a s t H e a l t h I n s t i t u t e

+61 7 5202 3017 [email protected] health.qld.gov.au/sunshinecoast

Telehealth Networks

Telehealth Networks was established in 2011 after 10 years of research into online consultations. Today, our team has developed a low-bandwidth video-conference system that is easy to use and incorporates integrated bluetooth devices.

The Telehealth system has been designed by health professionals who understand what’s required for a truly comprehensive telehealth consultation. One of the drawbacks experienced in a standard telehealth consultation is lack of vital data such as

ECG results, blood pressure readings, and the like. Our system overcomes this problem by using integrated bluetooth devices connected to a simple INSTAVITALS app that permits the display of real-time monitoring during each video conference.

The Telehealth system also includes modules for appointments and scheduling, medication management, and messaging and broadcasting, enabling instant communication with patients. HL7 communication makes the system secure and enables

sending of data to patient records in forms that can be integrated with existing patient medical records. All devices are FDA,CE, TGA approved.

Our platform has been implemented in Australia and India, with plans to expand to other countries in the near future.

Dr Ramana PandaC h a i r m a n a n d C h i e f O p e r a t i n g O f f i c e r

+61 7 5689 1500 [email protected] telehealthnetworks.com.au

64Trade 2018

Trad

e 20

18

| c

ompa

ny d

irec

tory

TriCare

A premium lifestyle with all the trimmings is offered at Sunnybank Hills, where the elegant atmosphere and superior amenities suit the most discerning of residents. In hotel-style surrounds, we provide care for residents with short-term respite and

permanent needs.

Our approach to care comes from the family values and genuine care that have underpinned TriCare for 50 years, ensuring that each resident receives the care to meet their individual needs, even as life changes.

We ensure residents keep engaged with daily social interaction, through our lifestyle activities and therapies, convivial dining and 24-hour staff presence.

Relax, knowing loved ones are in good hands, with TriCare.

1300 TRICARE tricare.com.au

The University of Queensland Diamantina Institute

The University of Queensland Diamantina Institute (UQDI) is a modern research facility where clinical and basic science are used to study cancer, immunology and genomic medicine. The Institute has a vibrant community of over 300 researchers,

students and support staff.

We have delivered global, world-changing discoveries to humanity, such as:

» Discovery, development and release of the world’s first cervical cancer vaccine

» Clinical trials of the vaccine program in developing countries

» Identification of genes responsible for one-third of the risk of developing ankylosing spondylitis

» Development of a new test to identify patients with the potential to develop diabetes

» Design of one the first needle-free vaccine technologies

» Discovery of gene-silencing technology for cancer treatment

» Identification of new genes involved in multiple sclerosis.

Based at the Translational Research Institute (TRI) beside the Princess Alexandra Hospital, UQDI has strong clinical interactions and world-class facilities that enable researchers to be at the forefront of their fields. UQDI’s position within the TRI allows for

a much greater collaborative research environment, allowing our researchers to focus their efforts on turning their scientific discoveries into new treatments for diseases including a variety of cancers, arthritis and other autoimmune diseases.

UQDI aims to translate research discoveries into the prevention and treatment of major diseases. As part of The University of Queensland’s prestigious Faculty of Medicine, UQDI is committed to making a global difference to health outcomes.

Dr Fiona Simpson-FraserQ H N C C S e n i o r R e s e a r c h F e l l o w

+61 7 3443 6930 [email protected] di.uq.edu.au



Thomson Adsett

Established in 1971, Thomson Adsett is a leading international architecture and design firm, with studios throughout Australia and Asia.

The firm’s flexible design thinking is reflected across a range of sectors, including seniors living, where we are leaders in innovative design.

Thomson Adsett has worked in aged care for more than 30 years, and completed senior-living projects in Queensland, Melbourne, China and Malaysia. The company participated in a highly successful TIQ aged-cared mission to China and

Hong Kong in late 2017. Also in 2017, Thomson Adsett was ranked number 1 in the world in the global elderly living sector by the UK architecture magazine Building Design. In January this year, Thomson Adsett Chairman David Lane shared his

expertise on senior-living facilities during a panel discussion at Hong Kong’s Golden Age Expo and Summit.

Thomson Adsett prides itself on delivering lasting architectural solutions, supported by well-designed business strategies, to ensure the commercial, social and cultural success of each project.

David LaneG r o u p D i r e c t o r – S e n i o r s L i v i n g

+61 7 3840 9999 [email protected] thomsonadsett.com

Translational Research Institute

The Translational Research Institute (TRI) is a leading Australian medical research, development and translational facility. It is home to a range of cutting-edge technologies, including interventions to prevent and treat human diseases, and provide

diagnosis of early disease.

TRI is supported by grants from the Australian and Queensland governments. Situated in the Princess Alexandra Hospital precinct, TRI combines the research intellect and capability of Queensland Health, The University of Queensland, Queensland

University of Technology and the Mater Hospital.

These shareholders offer TRI access to:

» Australia’s first large-scale digital hospital

» a university in the world’s top 50

» a university for the real world

» a private hospital providing clinical excellence.

TRI houses over 1,000 leading researchers and support scientists and 2 clinical trial facilities. TRI licenses space to 4 start-up companies and space in an adjacent building to the biopharmaceutical manufacturer Thermo Fisher.

TRI is charged with partnering with the commercial sector to ensure scientific innovations move rapidly to address unmet patient needs and generate income and jobs for the Australian economy. TRI is at the interface of science,

medicine and industry.

Dr Nagaraj GopisettyB u s i n e s s D e v e l o p m e n t a n d I n n o v a t i o n E d u c a t i o n M a n a g e r

+61 7 3443 7611 [email protected] tri.edu.au

66Trade 2018

Trad

e 20

18

| c

ompa

ny d

irec

tory

Trisco

The Precise range of products, including Enprocal, are the health and wellbeing brands of Trisco Foods. Trisco is owned and managed by the Tristram family, who have been manufacturing food and beverage products for five generations since 1875.

Precise Thick-N Instant has been a disruptive innovation, providing a precise, controllable dosage system that gives the confidence of a pre-thickened beverage consistency to dysphagia residents and their families. It is the world’s

leading liquid thickener.

Through our ongoing commitment to innovation, and our highly skilled food technologists, we have been able to inhibit the thickening capacity of gums in their liquid phase so that they only express their viscosity upon final addition to

another beverage.

Jenny XiangB u s i n e s s D e v e l o p m e n t M a n a g e r Q L D | P r e c i s e / E n p r o c a l

+61 7 3718 5800 [email protected] precisethicken.com.au enprocal.com.au

Tunstall Healthcare

Tunstall Healthcare is a leading provider of connected care and connected health solutions. With more than 60 years’ global experience and operations in more than 50 countries, Tunstall offers assistive technologies that enable older people and those

with long-term health needs to live more safely and independently.

Tunstall offers a truly end-to-end solution, encompassing design and development, consultancy and service support, deployment and training, and triage and monitoring services. Our operations in both Australia and New Zealand are long-

established service providers to government, retirement villages and community care organisations.

With alliances and partnerships across the region, we give clients a positive, reliable and consistent experience. Together, the Tunstall team strives to care for as many people as possible by listening to our customers and offering responsive solutions.

Lisa CapamagianM a r k e t i n g & P r o p o s i t i o n s M a n a g e r

+61 7 3637 2202 [email protected] tunstallhealthcare.com.au



University of Queensland – Centre for Advanced Imaging

The Centre for Advanced Imaging (CAI) brings together the skills of a critical mass of researchers and ‘state-of-the-art’ research imaging instruments.

CAI is the only facility of its type in Australia, and one of only a handful in the world. The 5,500 sq.m, $55 million CAI building was funded by the Federal Education Investment Fund in 2010 and contains over $50 million of imaging and spectroscopy

equipment, putting UQ’s researchers at the forefront of a swiftly advancing field.

CAI researchers work on innovations in spectroscopic and imaging technology, imaging biomarker development and in biomedical research disciplines, frequently in collaboration with clinical research sites and other local, national, and

international research institutes.

+61 7 336 54100 [email protected] cai.centre.uq.edu.au

University of Southern Queensland

The University of Southern Queensland (USQ) is a young, dynamic university, which in 25 years has become a leader in flexible and online study. With its major campus in the regional centre of Toowoomba, USQ is internationally recognised for delivering

practical, world-class research that delivers high-impact solutions.

Health is the focus for a number of USQ’s research projects. From super foods to regional cancer survival, USQ researchers are working to improve the quality of life for all. We are committed to conducting research that is not only academically relevant

but also engages with industry and stakeholders and contributes to innovation that benefits local communities, the nation and beyond. Key to USQ’s research culture is working with industry to understand problems facing the sector, and

collaborating to develop new ideas and technologies that have tangible benefits.

Dr Jodi RichardsM a n a g e r ( R e s e a r c h D e v e l o p m e n t )

+61 7 3470 4560 [email protected] usq.edu.au

68Trade 2018

Trad

e 20

18

| c

ompa

ny d

irec

tory

University of the Sunshine Coast

The USC Clinical Trials Centre is a world-class clinical trials centre bringing advanced treatments and breakthrough therapies to the Sunshine Coast – and beyond. The centre comprises a centrally administered network of more than 15 investigative

sites across general practices, private specialists and private hospitals, with capabilities across numerous therapeutic areas and phases of clinical research.

Lucas LitewkaD i r e c t o r

+61 429 930 449 [email protected] usc.edu.au/ctc

Vald Performance

Vald Performance strives to provide health and performance professionals with the right information to make the right decision at the right time. Combining advanced sensors with real-time data visualisation and analytics, Vald Performance testing systems

provide unparalleled insights into strength, performance and asymmetry, while remaining easy-to-use, fast and reliable. Since their launch, the NordBord Hamstring Testing System and GroinBar Hip Strength Testing System have become gold

standards for lower-limb strength assessment. The launch of the HumanTrak Movement Analysis System has enabled coaches to objectively and reliably assess movement quality to a standard of accuracy previously reserved for biomechanics labs.

Scott MunroP e r f o r m a n c e M a n a g e r

+61 429 930 449 [email protected] valdperformance.com

Virtual Diversionary Therapy Australia

Virtual Diversional Therapy Australia (VDTA) is a state-of-the-art organisation that provides customised virtual reality experiences to people who require diversional therapy. All of us at VDTA have a passion for diversional therapy, offering the people of Australia

the latest in technology and bringing happiness and joy to individuals alike.

This technology is the future in helping people deal with difficult situations they may find themselves in throughout life. We provide the most up-to-date and technologically advanced virtual reality diversional therapy. This therapy is tailored to each individual

clients’ needs. For example, if a client enjoyed a certain place such as their local beach, favourite lookout or family home, we can take them to these places through advanced virtual reality and cutting-edge camera and computer technology at a

very affordable price.

+61 7 3195 3931 [email protected] vdta.jimdo.com




10−12 OCTOBER 2018 BRISBANE AUSTRALIA

Presented by Host Partner

Join us Down Under in 2018!Australian Healthcare & Hospitals Association (AHHA) is pleased to invite you to join us in Australia for the 42nd IHF World Hospital Congress to be held on 10-12 October 2018 in sunny Brisbane.

Join health leaders from around the world to discuss how healthcare needs to evolve to meet 21st century demands. Globally, health systems are in transition. Impacts of new technology, changing demographics and disease profiles, funding pressures, new models of care and more are driving transformation. So how at this critical point do we harness the benefits and overcome the obstacles?

The 42nd IHF World Hospital Congress will inspire you with the journey to date and the opportunities for the future to come.

www.hospitalcongress2018.com

Platinum Sponsor

Important datesPreliminary program

announcedMarch 2018

Earlybird registration closes

30 June 2018

World Hospital Congress10-12 October 2018

Early bird registration now openRegister by 30 June 2018 for great discounts

A D V E R T 2

Connecting Queensland business to the world

tiq.qld.gov.au

All information is current at time of printing – subject to change.

tuesday 10 – friday 13 april - trade & investment queensland › wp-content › uploads ›...

Documents